Small caps did an article on today’s Ann. Note the following sentence:
Specifically, Camargo will assist Incannex to develop the non-clinical, clinical, pharmacological and biopharmaceutical strategy to be proposed to the FDA.
https://*********.com.au/incannex-healthcare-reveals-positive-in-vivo-results-meeting-fda/
Ann: Positive IHL-675A in vivo results and FDA Pathway, page-55
-
- There are more pages in this discussion • 70 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)